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 17 
Brief statement about novelty and impact: 18 
This study is the first to apply a quantitative approach for comparative risk assessment of different 19 
carcinogens in alcoholic beverages. Ethanol was found to be the most important ingredient leading to 20 
substantial cancer risk. This result clarifies misinformation that other contaminants are predominantly 21 
responsible for the carcinogenicity, e.g., claims by industry about carcinogenic contaminants, which are 22 
not contained in certain brand products. Until now, the scientific basis was lacking to refute such 23 
misleading advertisement claims. The developed methodology can also be transferred to other ingredients 24 
or to comparative risk assessment of other substances. 25 
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Abstract 26 
Alcoholic beverages have been classified as carcinogenic to humans. As alcoholic beverages are 27 
multi-component mixtures containing several carcinogenic compounds, a quantitative approach is 28 
necessary to compare the risks. 29 
Fifteen carcinogenic compounds (acetaldehyde, acrylamide, aflatoxins, arsenic, benzene, 30 
cadmium, ethanol, ethyl carbamate, formaldehyde, furan, lead, 4-methylimidazole, N-31 
nitrosodimethylamine, ochratoxin A, and safrole) occurring in alcoholic beverages were 32 
identified based on monograph reviews by the International Agency for Research on Cancer. The 33 
margin of exposure (MOE) approach was used for comparative risk assessment. MOEs were 34 
calculated for different drinking scenarios (low risk and heavy drinking) and different levels of 35 
contamination for four beverage groups (beer, wine, spirits, unrecorded alcohol). 36 
The lowest MOEs were found for ethanol (3.1 for low risk and 0.8 for heavy drinking). Lead and 37 
arsenic have average MOEs between 10 and 300, followed by acetaldehyde, cadmium and ethyl 38 
carbamate between 1,000 and 10,000. All other compounds had average MOEs above 10,000 39 
independent of beverage type. 40 
Ethanol was identified as the important carcinogen in alcoholic beverages, with a clear dose-41 
response curve. Some other compounds (lead, arsenic, ethyl carbamate, acetaldehyde) may pose 42 
risks below thresholds normally tolerated for food contaminants, but from a cost-effectiveness 43 
point of view, the focus should be on reducing alcohol consumption in general than on mitigative 44 
measures for some contaminants that contribute only in minor fashion (if at all) to the total health 45 
risk.  46 
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Introduction  47 
Since the first observation in France in the beginning of the last century that the consumption of 48 
absinthe was related to oesophageal cancer,1 epidemiology has established a causal relationship 49 
between alcohol consumption in general (i.e. independent of beverage type) and the occurrence 50 
of cancer. Moreover, in 1988, the International Agency for Research on Cancer (IARC) classified 51 
alcoholic beverages into group 1 as "carcinogenic to humans".2 At this time, a causal relationship 52 
between alcohol consumption and the occurrence of malignant tumours of the oral cavity, 53 
pharynx, larynx, oesophagus and liver was established. In the following IARC evaluations, colo-54 
rectum cancer and female breast cancer were added to the list of cancer sites with causal 55 
relationship, while only limited evidence points to stomach and pancreas as further sites.3-5 56 
While the epidemiological evidence on the carcinogenicity of alcoholic beverages had been 57 
sufficiently established for several decades, the principal mechanism underlying this relationship 58 
has been a matter of debate. For a long time it was assumed that ethanol itself was not a direct 59 
carcinogen. The 1988 IARC monograph, for example, stated that there is inadequate evidence for 60 
the carcinogenicity of ethanol in experimental animals.2 However, this statement was based on 61 
lack of well-controlled and designed experimental studies rather than on a clear absence of effect. 62 
Since then, two adequately designed long-term animal studies have clearly demonstrated that 63 
ethanol causes dose-related cancer in mice and rats at sites similar to those observed in humans 64 
(liver and oral cavity).6,7 As a result of this new evidence, the 2007 IARC evaluation concluded 65 
that there is sufficient evidence in experimental animals for the carcinogenicity of ethanol.3,5 66 
Furthermore, substantial mechanistic evidence has become available in humans who are deficient 67 
in aldehyde dehydrogenase that acetaldehyde derived from the metabolism of ethanol in alcoholic 68 
beverages contributes to the causation of malignant oesophageal tumours. Acetaldehyde reacts 69 
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with DNA to form various DNA adducts, and elevated levels of acetaldehyde-derived DNA 70 
adducts have been detected in white blood cells of individuals who are heavy alcoholic beverage 71 
drinkers. Some of the DNA adducts that are increased after alcoholic beverage consumption are 72 
mutagenic in human cells. In addition, these adducts can undergo rearrangements in double-73 
stranded DNA, which can result in the formation of DNA–protein cross-links and DNA 74 
interstrand cross-links, which are mechanistically consistent with the generation of chromosomal 75 
aberrations. Elevated levels of chromosomal aberrations have been observed in human cells in 76 
culture after exposure to acetaldehyde as well as in vivo in human alcoholics.3 This mechanistic 77 
evidence combined with the results in experimental animals and the epidemiological observation 78 
that all alcoholic beverages cause cancer demonstrate that ethanol is an important carcinogenic 79 
compound in alcoholic beverages. In their most recent evaluation, IARC has therefore classified 80 
both "ethanol in alcoholic beverages" as well as "acetaldehyde associated with alcohol 81 
consumption" into group 1 as "human carcinogens".4 82 
Nevertheless, misinformation is still spread that ethanol is not a carcinogen at all or that alcohol-83 
related cancer is exclusively caused by something else. For example, promotional material on an 84 
ethanol-containing mouthwash states that "ethanol is not a carcinogen; however, alcoholic 85 
beverages contain numerous carcinogenic compounds such as urethane, nitrosamines, polycyclic 86 
hydrocarbons and aflatoxins".8 While there is certainly ample evidence pointing to the fact that 87 
ethanol is the major carcinogenic compound in alcoholic beverages, the assumption about other 88 
carcinogens cannot be directly negated. Alcoholic beverages are multi compound mixtures and 89 
(similar to tobacco) may regularly contain various carcinogens such as those mentioned in the 90 
promotional material. The IARC also remarked that identification of ethanol as a known 91 
carcinogenic agent in alcoholic beverages does not rule out the possibility that other components 92 
may also contribute to their carcinogenicity.3 A summary of carcinogens typically occurring in 93 
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alcoholic beverages is provided in table 1. In fact some of these carcinogens in alcoholic 94 
beverages, and specifically ethyl carbamate (urethane), are seen by international bodies such as 95 
the Joint FAO/WHO Expert Committee on Food Additives (JECFA) or the European Food 96 
Safety Authority (EFSA) as public health risk independent of ethanol.9,10 For this reason, the 97 
European Commission has advised the member states to monitor the ethyl carbamate 98 
contamination in certain alcoholic beverages.11 Another example is N-nitrosodimethylamine 99 
(NDMA), which was first found in German beers in 1978,12 when concentrations of up to 100 
68 µg/L caused worldwide concern. A change in the target organ specificity of NDMA by co-101 
administration of ethanol was observed: when NDMA was given in combination with ethanol, 102 
rats and mice developed tumours in the nasal cavity, which is not a target site for this 103 
nitrosamine. This suggests that ethanol may influence the initiation of carcinogenesis in some 104 
manner, but it is also possible that the process is enhanced due to some mechanistic events: the 105 
facilitation of entry into the target cell by ethanol, a change in intracellular metabolism or 106 
suppression of DNA repair. The hypothesis of competitive inhibition of hepatic metabolism of 107 
the carcinogen, which allows it to reach the target organs, has also been proposed.3 The questions 108 
about the risk posed by other substances other than ethanol is especially important for unrecorded 109 
(i.e. illicitly or home-produced) alcohol, which is assumed to potentially contain higher 110 
concentrations of contaminants, especially ethyl carbamate and acetaldehyde.13,14 111 
The literature currently offers no quantitative information if and how much other carcinogenic 112 
constituents or contaminants of alcoholic beverages compare with and contribute to the risk 113 
generated by ethanol. Such information is necessary especially to inform risk management to 114 
prioritize cancer prevention.  115 
Several approaches were suggested in the past for quantitative risk assessment of carcinogens.15 116 
From these, the so-called margin of exposure (MOE) approach is currently preferred by 117 
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international bodies such as WHO16 or EFSA17, for recent review see Benford et al.18. This study 118 
will therefore apply the MOE approach to provide a comparative risk assessment of carcinogens 119 
occurring in alcoholic beverages. The results will be used to point out options for alcohol policy. 120 
Methods 121 
The selection of carcinogens and their occurrence in alcoholic beverages was based on the most 122 
recent detailed IARC review,3 for exceptions see remarks in results section. The assessment of 123 
toxicological endpoints and benchmark doses (BMD) for the selected carcinogens was generally 124 
based on literature data, as own dose-response modelling would have gone beyond the scope of 125 
this study. Suitable risk assessment studies including endpoints and dose-response modelling 126 
results were typically identified in monographs of national and international risk assessments 127 
bodies such as WHO International Programme on Chemical Safety (IPCS), JECFA, US 128 
Environmental Protection Agency (EPA) and EFSA. For substances without available 129 
monographs or with missing data on dose-response modelling results, the scientific literature in 130 
general was searched for such data. Searches were carried out in September 2011 in the following 131 
databases: PubMed (U.S. National Library of Medicine, Bethesda, MD), Web of Science 132 
(Thomson Reuters, Philadelphia, PA), Scopus (Elsevier B.V., Amsterdam, the Netherlands), and 133 
Google Scholar (Google Inc., Mountain View, CA).  134 
The BMD/MOE approach was used for risk assessment.17,19,20 Based on dose-response 135 
modelling, the BMD is the point on the dose response curve, which characterizes adverse effects. 136 
This value can then be used in combination with exposure data to calculate a MOE for 137 
quantitative risk assessment. The MOE is defined as the ratio between the lower one-sided 138 
confidence limit of the BMD (BMDL) and estimated human intake of the same compound. It can 139 
be used to compare the health risk of different compounds and in turn prioritize risk management 140 
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actions. By definition, the lower the MOE, the larger the risk for humans; generally a value under 141 
10,000 used to define public health risks.21 142 
If BMDL values were unavailable in the literature, no observed effect level (NOEL) or no 143 
observed adverse effect level (NOAEL) values were identified as surrogate thresholds instead. 144 
The MOEs were then calculated by dividing the NO(A)EL by the estimated human intake.  145 
For each beverage group (i.e. beer, wine, spirits and unrecorded alcohol), the human intakes were 146 
calculated for two different drinking scenarios (low risk drinking and heavy drinking) based on 147 
the drinking guidelines for Canada, which consider that 13.6 g pure alcohol constitute a standard 148 
drink.22 For both drinking scenarios, MOEs for average contamination as well as maximum 149 
contamination with the different carcinogens were additionally calculated to estimate a range for 150 
average and worst case contamination scenarios.  151 
Results  152 
Alcoholic beverages may contain more than 1,000 different components,2 from which several are 153 
potentially carcinogenic. In the first step of the comparative risk assessment, a selection of 154 
compounds for further evaluation has to occur. The IARC Monographs Working Group Vol. 963 155 
compared the complete IARC list of carcinogens with the list of compounds regularly occurring 156 
in alcoholic beverages (appendix 1 in the IARC 1988 monograph2) and provided a summary of 157 
carcinogens that may be present in alcoholic beverages (see table 1.14, p. 113 in the IARC 2010 158 
monograph3). From this summary, we have chosen the compounds set into IARC group 1 159 
(carcinogenic to humans), IARC group 2A (probably carcinogenic to humans) and IARC group 160 
2B (possibly carcinogenic to humans) to be included in our evaluation. Compounds set into 161 
IARC group 3 (not classifiable as to its carcinogenicity to humans) such as deoxynivalenol, 162 
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nivalenol, organolead compounds and patulin were excluded from our evaluation. The remaining 163 
compounds in groups 1, 2A and 2B were acetaldehyde, acrylamide, aflatoxins, arsenic, benzene, 164 
cadmium, ethanol, ethyl carbamate, furan, lead, NDMA, and ochratoxin A (Table 1). Since the 165 
writing of the exposure section in the IARC Monograph Vol. 96 in 2007 (two of the authors of 166 
this article, DWL and JR, were members of this working group and contributed to the initial 167 
evaluation), additional evidence for some compounds has become available. For example, the 168 
regular occurrence of formaldehyde, an IARC group 1 carcinogen, in alcoholic beverages was 169 
detected.23 Furthermore, 4-methylimidazole a contaminant of caramel colours with known use in 170 
certain alcoholic beverages,24,25 was newly evaluated by IARC in 2011 and set into group 2B.26 171 
Safrole, another group 2B substance, may also potentially occur in alcoholic beverages.27 Safrole 172 
is a flavour compound with a comparably high ranking in the Berkeley carcinogenic potency 173 
project due to its occurrence in spices.28 Therefore, formaldehyde, 4-methylimidazole and safrole 174 
were added to our list (Table 1).  175 
The data on occurrence of the chosen compounds in alcoholic beverages are summarized in Table 176 
2. Data on recorded alcohol (i.e. commercial wine, beer and spirits) were predominantly based on 177 
the summaries in the IARC 2010 monograph3. In some instance, actualized data from 178 
international surveys (e.g. from EFSA) were available (see details in Table 229-33). Less data on 179 
unrecorded alcohol is generally available.13,34 The data were therefore taken from an own survey 180 
recently conducted in the European Union.14  181 
In general, the contamination of alcoholic beverages with the selected compounds is subject to a 182 
wide variation depending on product category, raw material, or diligence during manufacturing. 183 
The substances typically occur at ppb-levels or below, e.g. for aflatoxins, cadmium, or ochratoxin 184 
A. The exception are ethyl carbamate and formaldehyde, which may reach ppm-levels but only in 185 
certain products, while acetaldehyde typically occurs in ppm-levels in all product categories 186 
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(besides vodka and neutral alcohol-based products), and may even exceed 1 g/L in certain highly 187 
contaminated products. No clear difference between commercial and unrecorded alcoholic 188 
beverages was detected with the exception of lead that may exceed 1 mg/L in highly 189 
contaminated unrecorded alcohol.  190 
The toxicological endpoints used for dose-response modelling and the chosen points of departure 191 
for MOE assessment are shown in Table 3.6,10,21,35-62 According to international guidelines for 192 
risk assessment using the MOE approach,16-18,20 the most sensitive toxicological endpoint was 193 
chosen, when several endpoints were available. For some agents such as formaldehyde, benzene 194 
or lead, non-cancer endpoints were more sensitive than cancer endpoints or cancer endpoints 195 
were unavailable. To provide a conservative assessment, we decided to use these non-cancer 196 
endpoints in these cases. For a third of the compounds, human epidemiological data were 197 
available suitable for dose-response modelling. For the rest of the compounds, the assessments 198 
have to be based on animal data. The effective doses of the compounds as expressed by BMDL 199 
vary over a very wide range, from 0.00087 mg/kg bw/day for aflatoxin B1 to 700 mg/kg bw/day 200 
for ethanol.  201 
Table 4 shows the corresponding MOEs for several scenarios and alcoholic beverage groups. An 202 
average over all groups is provided in Figure 1. The lowest MOEs were calculated for ethanol, 203 
with 3.1 for low risk drinking and 0.8 for heavy drinking. Lead and arsenic have average MOEs 204 
between 10 and 300, followed by acetaldehyde, cadmium and ethyl carbamate between 1,000 and 205 
10,000. Safrole, ochratoxin A, NDMA, 4-methylimidazole, furan, formaldehyde, aflatoxin B1 206 
and acrylamide have average MOEs above 10,000, even in the heavy drinking scenario. 207 
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Discussion 208 
Our study provides the first comprehensive comparison of the risk related to compounds in 209 
alcoholic beverages. It is interesting to note that from all evaluated agents, ethanol exhibits the 210 
lowest potency in terms of BMDL in mg/kg bw/day required to produce an effect. Nevertheless, 211 
due to its very high exposure as a major constituent of alcoholic beverages, this situation is 212 
completely reversed in terms of MOE, where now ethanol has the highest potency, as all other 213 
substances occur at considerably lower concentrations in order to produce the same effect. The 214 
observation that the MOE of ethanol is already in an effective dose range for the low risk 215 
drinking guideline for females is absolutely in line with epidemiological observations. For breast 216 
cancer, as an example, the largest pooled study on breast cancer shows significant effects for 217 
lower than one drink daily.63  218 
Interestingly, a similar comparative risk assessment that was recently conducted for tobacco 219 
carcinogens64 did not detect a single compound responsible for the carcinogenic effect as it was 220 
in our case for ethanol in alcoholic beverages. In tobacco, acrolein, formaldehyde, and cadmium 221 
all had MOEs down to below 10 and several other compounds had MOEs below 1000.64 222 
Our result for ethanol (MOE of 3.1 for one drink per day) is in excellent agreement with the 223 
result from the Berkeley Carcinogenic Potency Database (CPDB) project,28 which reported a 224 
MOE of 3 for moderate daily drinking (based on ethanol exposure of 326 mg/kg/day). It is of 225 
note that the CPDB project uses different methodology to calculate MOE (based on adjusted 226 
TD50 values from older animal experiments65 and not BMDL10 from the most recent NTP study 227 
as in our case21). As the results are almost the same, this independently validates our approach. 228 
The CPDB project also reported data on NDMA in beer before 1979 (MOE of 1,000) and NDMA 229 
in beer 1994-1995 (MOE of 50,000), which is also in agreement with our MOE results and the 230 
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general observation that NDMA in beer is nowadays of negligible risk due to changes in 231 
production technology.66 232 
A limitation of our study is the fact that the MOE estimations for several of the other compounds 233 
are not as robust as those for ethanol. For ethanol, not only the BMDL10 from animal experiments 234 
is available but also human BMD modelling data for several endpoints including liver cirrhosis 21 235 
as well as liver markers and blood pressure,67,68 all of which are in the same order of magnitude 236 
confirming the validity and inter-species transferability of the animal data. As no BMDL for 237 
cancer effect of ethanol was available in the literature, we used the animal BMDL for this study. 238 
For several of the other compounds, no epidemiological data was available or it was inconclusive 239 
(signified by classification into IARC groups 2A and 2B). Two major problems of such 240 
assessments remain: extrapolating between species as well as extrapolating from high-doses in 241 
animals to low-doses in humans.69 Our approach would therefore rather overestimate the risks of 242 
these agents compared to ethanol, for which these problems do not arise. A second limitation of 243 
the study would also lead to overestimation of the risks of all compounds besides ethanol: the 244 
limited database on occurrence data of these compounds in alcoholic beverages. For most of the 245 
compounds large international surveys are missing, which would be necessary to provide more 246 
robust exposure estimations. The exception of this is ethyl carbamate, for which large 247 
international and EU-wide surveys have been conducted.9,10 Such data are especially lacking for 248 
aflatoxins, cadmium, lead, and ochratoxin A. Several compounds also occur in only one category 249 
of beverages (e.g., acrylamide and furan are only expected in beer, while 4-methylimidazole may 250 
only occur in caramel-coloured products). In these cases, the absence of data can be explained by 251 
the unlikelihood of occurrence, which explains that some groups of beverages were not studied at 252 
all in the context of risk-oriented monitoring programs (see, e.g. Roth et al.70). We also assume 253 
that there is a publication bias favouring positive results.71 From own experience in our research 254 
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projects about unrecorded alcohol we know that it is much more problematic to publish survey 255 
results indicating no public health relevance rather than alarmist reports of methanol deaths, for 256 
example. From the typical lack of studies reporting absence of contamination in alcoholic 257 
beverages, along with own experience as alcohol control authority (that routinely tests for 258 
chemical contamination), we think that the occurrence data reported in table 2 are most likely 259 
biased towards higher levels. This observation even strengthens our argumentation that ethanol is 260 
the real risk factor in alcoholic beverages, as even with the available (most likely biased) 261 
occurrence data, the MOEs of all other compounds are considerably higher than the MOE of 262 
ethanol.  263 
Conclusion 264 
There are two main conclusions. First, the MOE approach is excellently suitable to provide 265 
comparative risk assessments for lifestyle factors that are mixtures of several toxic compounds 266 
such as alcoholic beverages. Second, ethanol was confirmed as by far the most important 267 
carcinogen in alcoholic beverages. This confirms deductions by other approaches (such as genetic 268 
epidemiology and mechanistic considerations, see introduction). This observation ultimately 269 
leads to the question if mitigation measures for the other carcinogens (e.g. as currently conducted 270 
for ethyl carbamate) are an adequate policy or if the money should not rather be spent on 271 
reducing alcohol consumption per se, for which several cost-effective measures are already 272 
available.72 The focus on alcohol policy would also not only reduce alcohol-related cancer but 273 
alcohol-related harm in general. The German Federal Institute for Risk Assessment, for example, 274 
holds the view in their assessment of acetaldehyde as contaminant of alcoholic beverages that 275 
mitigation measures are not required in this case, as alcoholic beverages are health damaging 276 
anyway.73 On the one hand, we agree of course with this statement as alcoholic beverages per se 277 
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certainly pose inherent health risks. However, it also disregards the obligation of the regulating 278 
agency to provide the safest possible environment. In modern societies we accept the fact that 279 
citizens take risks, including risks, which are potentially lethal (e.g., by drinking alcohol or 280 
exercising risky sports). However, within this risk taking the regulating agencies have to make 281 
sure that the environment in which individual risk taking occurs is the safest possible (see 282 
Refs.74,75 for further elaboration of these arguments). We would not argue to tolerate not closing a 283 
ski slope with present danger of avalanche based on the reasoning that skiing is dangerous 284 
anyway. In other words, reducing directly contained acetaldehyde in alcoholic beverages, which 285 
is technically possible,35,76 should be targeted by regulating agencies, as it would reduce risk of 286 
cancer independent of any individual risk decision. Our society cannot on the one hand tolerate 287 
the use of alcoholic beverages and regulate them within food laws (as is the case in the European 288 
Union) but then allow an exception regarding quality and safety. The individual drinker would 289 
also most certainly select uncontaminated alcohol over contaminated alcohol. 290 
In this context, it is noteworthy that for many of the mentioned contaminants, no maximum limits 291 
are set by legislation that would allow adequate control and enforcement of quality standards.34 292 
At least for one of the compounds, ethyl carbamate, mitigativ  risk management approaches are 293 
ongoing but only on a "recommendation" basis.11 Inorganic compounds such as lead or arsenic 294 
could be relevant for future research as was previously suggested in an analysis focused on 295 
wine.77 However, the problem of lead is not restricted to alcoholic beverages, which contribute 296 
only about 7% to the total lead exposure from foods and beverages.51 As the MOEs for total lead 297 
exposure may reach down to 1,51 risk management strategies outside of alcohol policy appear to 298 
be necessary for this metal. 299 
A final conclusion is the interesting observation that there is basically no substantial difference in 300 
risk between unrecorded and recorded alcohol as it was sometimes differently purported by the 301 
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alcohol industry.78 We also see no scientific basis for advertising claims that certain alcoholic 302 
beverages are more or less carcinogenic than others (e.g. red wine less than spirits). 303 
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Table 1. Summary of WHO International Agency for Research on Cancer (IARC) evaluation of 556 
carcinogenicity of substances that may be present in alcoholic beverages (updated from 557 
IARC3) 558 
IARC Monographs evaluation of 
Carcinogenicity Agent 
In animals In humans IARC group a 
IARC Monographs (Volume 
Number) 
Acetaldehyde associated with 
consumption of alcoholic 
beverages 
Sufficient Sufficient 1 36, Sup 7, 71, 100E 
Acrylamide Sufficient Inadequate 2A 60 
Aflatoxins Sufficient Sufficient 1 56, 82, 100F 
Arsenic Sufficient Sufficient 1 23, Sup 7, 100C 
Benzene Sufficient Sufficient 1 29, Sup 7, 100F 
Cadmium Sufficient Sufficient 1 58, 100C 
Ethanol in alcoholic 
beverages Sufficient Sufficient 1 44, 96, 100E 
Ethyl carbamate (urethane) Sufficient Inadequate 2A 7, Sup 7, 96 
Formaldehyde Sufficient Sufficient 1 88, 100F 
Furan Sufficient Inadequate 2B 63 
Lead compounds, inorganic Sufficient Limited 2A 87 
4-Methylimidazole Sufficient Inadequate 2B 101 
N-Nitrosodimethylamine Sufficient Inadequate 2A 17, Sup 7 
Ochratoxin A Sufficient Inadequate 2B 56 
Safrole Sufficient Inadequate 2B 10, Sup 7 
a
 Group 1: Carcinogenic to humans; Group 2A: Probably carcinogenic to humans; Group 2B: 559 
Possibly carcinogenic to humans (for definitions of groups, see monographs.iarc.fr). 560 
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Table 2. Occurrence of WHO International Agency for Research on Cancer (IARC) carcinogens 561 
in alcoholic beverages 562 
Agent Amount in alcoholic beverages (Average/Maximum)a Amount in unrecorded alcohol (Average/Maximum)b 
Acetaldehyde associated with 
consumption of alcoholic 
beverages 
9/63 mg/l (beer); 34/211 mg/l (wine); 66/1159 mg/l (spirits) 76 90/822 mg/l  
Acrylamide 0-72 µg/kg (beer) c  (no data) 
Aflatoxins 0.002/0.230 µg/L (beer) 29 (not detectable in all samples)  
Arsenic 0/102.4 µg/L (beer); 4/14.6 µg/L (wine); 13/27 µg/L (spirits)  (not detectable in all samples)  
Benzene 10/20 µg/L in beer produced with contaminated CO2  (no data) 
Cadmium 0.9/14.3 µg/L (beer); 1.0/30 µg/L (wine); 6/40 µg/L (spirits) 0/0.04 mg/L  
Ethanol in alcoholic 
beverages (2-80% vol) (10-89% vol)  
Ethyl carbamate (urethane) 0/33 µg/kg (beer); 5/180 µg/kg (wine); 93/6730 µg/kg (spirits); 744/22000 µg/kg (fruit spirits) 9 0.5/5.4 mg/L  
Formaldehyde 0 mg/L (beer); 0.13/1.15 mg/L (wine); 0.50/14.37 mg/L (spirits) 23 0.22/6.71 mg/L 23 
Furan 3.3/28 µg/kg (beer) 30 (no data) 
Lead compounds, inorganic 2/15 µg/L (beer) 31; 57/326 µg/L (wine) 32; 31/600 µg/L (spirits) 0.03/1.4 mg/L  
4-Methylimidazole Caramel colored products: 9/28 µg/L in dark beer 
24; 0/0.14 mg/L in 
whisky 25 (no data) 
N-Nitrosodimethylamine 0.1/1.3 µg/kg (beer) (no data) 
Ochratoxin A 0.05/1.5 µg/L (beer); 0.23/7.0 µg/L (wine) (no data) 
Safrole 0/6.6 mg/l (bitters/liqueurs/aperitifs) 27 (no data) 
a
 If no other source is stated, the data are taken from the IARC literature review3 by calculating 563 
the average over all studies. Historical data (i.e. prior to implementation of mitigation 564 
measures) was not included. 565 
b If no other source is stated, the data are taken from an European sample of unrecorded alcohol14 566 
c
 Few surveys on acrylamide in alcoholic beverages are available. The majority of analyzed 567 
samples contained levels below the detection limit. The level of 72 µg/kg was reported in 568 
a single sample of wheat beer.33569 
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Table 3. Dose response modelling results of WHO International Agency for Research on 570 
Cancer (IARC) carcinogens occurring in alcoholic beverages 571 
Agent Toxicological Endpoint for Modelling a 
Reference for 
Dose-Response 
Modelling Study 
Reference for 
Original Data used 
for Modelling 
BMDL10 b 
[mg/kg bw/day] 
Acetaldehyde Tumour-bearing animals in 
male rats 
35
 
36
 56  
Acrylamide Harderian gland tumours in 
mice 
37
 
38
 0.18  
Aflatoxin B1 Liver cancer in humans 39 40 0.00087  
Arsenic Lung cancer in humans 41 42 BMDL0.5: 0.003 
Benzene Lymphocyte count in humans 43 44 1.2 
Cadmium Human studies involving 
chronic exposures 
45
 
45
 NOAEL: 0.01 c 
Ethanol Hepatocellular adenoma or 
carcinoma in rats 
21
 
6,46
 700 
Ethyl carbamate (urethane) Alveolar and bronchiolar 
neoplasms in mice 
10
 
46
 0.3 
Formaldehyde Histological changes in the 
aerodigestive tract, including 
oral and gastrointestinal 
mucosa of rats 
47
 
48
 NOEL: 15 c 
  
Furan Hepatocellular adenomas and 
carcinomas in female mice 
49
 
50
 0.96  
Lead Cardiovascular effects in 
humans 
51
 
52
 BMDL01: 0.0015 
4-Methylimidazole Cancer of the lung in mice 53 54 NOAEL: 80 c 
N-Nitrosodimethylamine Total liver tumors 55 56,57 0.029 
Ochratoxin A Kidney adenoma and 
carcinoma in male rats 
58
 
59
 0.025  
Safrole Hepatic tumors in mice 60 61,62 3 d 
a Human data was preferred over animal data, if available. Non-cancer endpoints were chosen if 572 
dose-response modelling for cancer effects was unavailable (such as in the case of lead). 573 
The most sensitive endpoint was chosen if dose-response data for several organ sites were 574 
available. 575 
b
 BMDLx: lower one-sided confidence limit of the benchmark dose (BMD) for a x% incidence of 576 
health effect.  577 
c
 No usable BMD-modelling for oral exposure was identified in the literature. The No Effect 578 
Level (NOEL) or No Observed Adverse Effect Level (NOAEL) are used in these cases 579 
instead. 580 
d
 A range of "approximately 3-29 mg/kg bw/day" was provided as BMDL10 for safrole 60. As no 581 
further rationale was provided in the study, we chose the minimum of this range to 582 
provide a conservative assessment. 583 
 584 
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Table 4. Margin of Exposure (MOE) of WHO International Agency for Research on Cancer 585 
(IARC) carcinogens occurring in alcoholic beverages calculated for different drinking and 586 
contamination scenarios (MOE = BMDL or NO(A)EL / Exposure) 587 
Scenario 1: One standard drink 
per day (low risk drinking 
guideline for females) a 
Scenario 2: Heavy drinker (4 standard 
drinks per day, own categorization) a 
Agent Type of alcohol 
MOE for average 
contamination 
MOE for 
maximum 
contamination 
(Worst case) 
MOE for average 
contamination 
MOE for maximum 
contamination (Worst 
case) 
Beer 1095 156 274 39 
Wine 696 112 174 28 
Spirits 1184 67 296 17 
Acetaldehyde b 
Unrecorded 868 95 217 24 
Acrylamide Beer ∞ c 440 ∞ 110 
Aflatoxin B1 Beer 76540 666 19135 166 
Beer ∞ 5 ∞ 1 
Wine 317 87 79 22 
Arsenic 
Spirits 322 155 81 39 
Benzene Beer 21114 10557 5279 2639 
Beer 1955 123 489 31 
Wine 4225 141 1056 35 
Spirits 2326 349 581 87 
Cadmium 
Unrecorded ∞ 349 ∞ 87 
Ethanol All 3.1 - 0.8 - 
Beer ∞ 1600 ∞ 400 
Wine 25352 704 6338 176 
Spirits 4501 62 1125 16 
Fruit spirits 563 19 141 5 
Ethyl carbamate 
(urethane) 
Unrecorded 837 78 209 19 
Beer ∞ ∞ ∞ ∞ 
Wine 48754 5511 12189 1378 
Spirits 41860 1457 10465 364 
Formaldehyde 
Unrecorded 95137 3119 23784 780 
Furan Beer 51186 6033 12797 1508 
Beer 132 17.6 33 4.4 
Wine 11 1.9 2.8 0.5 
Spirits 68 3.5 17 0.9 
Lead  
Unrecorded 70 1.5 17 0.4 
Caramel-coloured Beer 1564027 502723 391007 125681 4-Methylimidazole 
Caramel-coloured 
Whisky ∞ 797342 ∞ 199336 
N-
Nitrosodimethylamine 
Beer 51026 3925 12757 981 
Beer 87977 2933 21994 733 Ochratoxin A 
Wine 45928 1509 11482 377 
Safrole Bitters/Liqueurs/Aperitif
s 
∞ 634 ∞ 159 
b
 A standard drink in Canada is considered to have a total of 13.6 grams of alcohol 22. To 588 
recalculate the amount of contaminants per L or per kg to standard drink, portions of 341 589 
ml (beer), 142 ml (wine), 43 ml (spirits and unrecorded) were chosen 22. As no density 590 
was given in any of the contamination studies, 1 kg was set to equal 1 L for recalculation 591 
to volume if necessary. The exposure was estimated for the different drinking scenarios 592 
based on the occurrence data in Table 2 and a body weight of 60 kg. 593 
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b
 Acetaldehyde directly contained in the beverages excluding metabolically formed acetaldehyde.  594 
c
 The lemniscate symbol indicates that the MOE was not calculable as the exposure was zero (i.e. 595 
below the detection limit of the applied analytical methodology) 596 
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Acetaldehyde
Acrylamide
Aflatoxin B1
Arsenic
Benzene
Cadmium
Ethanol
Ethyl carbamate (urethane)
Formaldehyde
Furan
Lead 
4-Methylimidazole
N-Nitrosodimethylamine
Ochratoxin A
Safrole
1 10 100 1000 10000 100000
Margin of Exposure (MOE) for 4 drinks per day597 
Figure 1. Margin of Exposure (MOE) for carcinogens occurring in alcoholic beverages for heavy 598 
drinking scenario (averages based on data from table 4; error bar indicates worst case 599 
contamination). 600 
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